Table 2.
Demographic and clinical characteristics of the test cohorts across anastomotic leakage (N=358)
| Variables | Anastomotic leakage | Non-Anastomotic leakage | X2 | P |
|---|---|---|---|---|
| Age | 5.277 | 0.022 | ||
| ≥60 years | 21 (13.13%) | 139 (38.83%) | ||
| <60 years | 12 (6.06%) | 186 (51.96%) | ||
| Gender | 6.643 | 0.01 | ||
| Male | 25 (12.8%) | 170 (47.49%) | ||
| Female | 8 (4.9%) | |||
| Distance from the tumor to the anus | 4.602 | 0.032 | ||
| ≤7 cm | 24 (12.2%) | 173 (48.32%) | ||
| >7 cm | 9 (5.6%) | 152 (42.46%) | ||
| TNM Stage | 6.195 | 0.013 | ||
| ≥IIIa stage | 22 (13.3%) | 143 (39.94%) | ||
| ≤IIb stage | 11 (5.7%) | 182 (50.84%) | ||
| Preoperative albumin | 0.041 | 0.839 | ||
| ≤35 g/L | 2 (10.5%) | 17 (4.75%) | ||
| >35 g/L | 31 (9.1%) | 308 (86.03%) | ||
| Preoperative anemia | 0.693 | 0.405 | ||
| Yes | 5 (12.2%) | 36 (10.06%) | ||
| No | 28 (8.8%) | 289 (80.73%) | ||
| Preoperative obstruction | 5.679 | 0.017 | ||
| Yes | 9 (18.37%) | 40 (11.17%) | ||
| No | 24 (7.77%) | 285 (79.61%) | ||
| Diabetes | 3.734 | 0.053 | ||
| Yes | 5 (20.0%) | 20 (5.59%) | ||
| No | 28 (8.4%) | 305 (85.20%) | ||
| Neoadjuvant chemotherapy | 0.216 | 0.642 | ||
| Yes | 2 (12.5%) | 14 (3.91%) | ||
| No | 31 (9.1%) | 311 (86.87%) | ||
| Defunctioning stoma | 5.32 | 0.021 | ||
| Yes | 1 (1.59%) | 62 (17.32%) | ||
| No | 32 (10.85%) | 263 (73.46%) |